Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PIRADS 5 findings on prostate MRI


Monday, April 13th 2026

Sundaresan VM, Webb L, Rabil M, Golos A, Sutherland R, Bailey J, Rajwa P, Seibert TM, Loeb S, Cooperberg MR, Catalona WJ, Sprenkle PC, Kim IY, Leapman MS.

“Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PIRADS 5 findings on prostate MRI”

Urol Oncol. 2025 Mar;43(3):193.e19-193.e26. PMID: 39706698

Link: https://pubmed.ncbi.nlm.nih.gov/39706698/

Comments are closed.